ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

April 7, 1978

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Funding Opportunities

September 6, 2002